What antibiotic can be used for both acute otitis media and acute bacterial sinusitis in a patient who cannot tolerate amoxicillin?

Antibiotic Selection for Patients Unable to Tolerate Amoxicillin

For patients who cannot tolerate amoxicillin, cefdinir, cefuroxime, or cefpodoxime are the recommended first-line alternatives for treating both acute otitis media (AOM) and acute bacterial sinusitis (ABRS), as these second- and third-generation cephalosporins provide excellent coverage against the common pathogens in both conditions. 1

Recommended Alternative Antibiotics

Second- and Third-Generation Cephalosporins (Preferred)

Cefdinir is highly suitable for both conditions:

• Pediatric dosing: 14 mg/kg/day in 1 or 2 doses 1
• Provides excellent coverage against S. pneumoniae, H. influenzae, and M. catarrhalis 1
• Third-generation agent with enhanced activity against β-lactamase-producing organisms 1

Cefuroxime axetil is another strong option:

• Pediatric dosing: 30 mg/kg/day in 2 divided doses 1
• Twice-daily administration with significantly enhanced activity against β-lactamase-producing H. influenzae, M. catarrhalis, and S. aureus 1
• Available as suspension for young children, though unpalatable 1

Cefpodoxime is equally effective:

• Pediatric dosing: 10 mg/kg/day in 2 divided doses 1
• Suitable agent for both AOM and sinusitis 1

Important Considerations for Cephalosporin Use

Cross-reactivity with penicillin allergy is minimal for second- and third-generation cephalosporins. The previously cited 10% cross-sensitivity rate is an overestimate based on outdated data from the 1960s-1970s 1. Due to differences in chemical structures, cefdinir, cefuroxime, and cefpodoxime are highly unlikely to be associated with cross-reactivity with penicillin 1. These agents can be safely used in patients with non-Type I hypersensitivity reactions (e.g., rash) 1.

Agents to Avoid

Do NOT use cefixime or ceftibuten for either condition:

• Both have poor activity against S. pneumoniae and are especially ineffective against penicillin-resistant strains 1
• Neither should be used for acute bacterial sinusitis 1

Macrolides (azithromycin, clarithromycin) are NOT recommended as first-line alternatives:

• Relatively weak against penicillin-resistant H. influenzae and S. pneumoniae 1
• High prevalence of macrolide-resistant S. pneumoniae in the United States (>40%) 1
• Should only be considered in cases of serious β-lactam allergy 1

Trimethoprim-sulfamethoxazole is NOT recommended:

• High resistance rates among S. pneumoniae (50%) and H. influenzae (27%) 1
• Surveillance studies show significant resistance, making it inappropriate for penicillin-allergic patients 1

Alternative for True β-Lactam Allergy

For patients with Type I hypersensitivity (IgE-mediated) to all β-lactams, respiratory fluoroquinolones are appropriate in adults:

• Levofloxacin or moxifloxacin for sinusitis 1
• Fluoroquinolones are generally not recommended for children due to concerns about developmental joint formation, though recent data suggest the risk is less than 1% 1

Treatment Duration

• 10-14 days is the standard duration for both AOM and sinusitis 1
• Shorter courses (5-7 days) may be appropriate for uncomplicated cases with mild presentation 1
• Continue treatment until symptom-free plus 7 additional days is an alternative strategy 1

Common Pitfalls

Avoid prescribing first-generation cephalosporins (cephalexin, cefadroxil) as they have poor coverage for H. influenzae and are inappropriate for these infections 1. Avoid cefaclor due to inadequate activity against β-lactamase-producing organisms and high prevalence of serum sickness-like reactions 1.